The American Journal of Managed Care

Expanding Access to Bispecifics in Myeloma While Navigating Reimbursement Nuances

Expanding bispecific antibody access for multiple myeloma involves collaboration between academic centers and community ...

Nebius: It's Beginning To Look A Lot Like Trouble

Nebius Group N.V. delivers explosive AI infrastructure growth but faces excessive risk and an unsustainable valuation. Read ...
TMCnet

The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS

(Nasdaq: BIIB) – today announced that The Journal of the American Medical Association (JAMA) Neurology has published final results from the completed Phase 3 VALOR study and its open-label extension ...
Le Lézard

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor

Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of ...

JEE Main 2026 last 30 days study plan: Expert tips, timetable & revision strategy for high score

The JEE Main Session 1 exam is scheduled from January 21 to 30, 2026, and this final 30-day period is crucial for focused revision, mock practice, and sharpening exam-ready skills. With just one month ...